Australian optometrists and ophthalmologists are collaborating to establish criteria for a new international myopia registry. The registry is launching via the University of Sydney’s Save Sight Registries, said Sydney ophthalmologist and founder of Myopia Australia, Dr Loren Rose. “It’s still early in its evolution but progressing well. We are gathering an international panel of experts to finalise the fields collected and review the data.”

The plan is to log all treatments available internationally, including atropine, and review the registry’s data every 3-6 months, said Dr Rose. “It’s hoped these data might offer some validation for low-dose atropine's use in myopes. Real-world data will help us understand treatments and outcomes and, being international, we hope it will shed light on (how they impact) different ages and ethnicities,” she said.

New Zealand's eyecare professionals can register to submit their data via Save Sight’s international portal once it is up and running, said Dr Rose.

For more, see www.savesightregistries.org